Nasopharyngeal carcinoma—Review of the molecular mechanisms of tumorigenesis

Nasopharyngeal carcinoma (NPC) is a head and neck cancer rare throughout most of the world but common in certain geographic areas, such as southern Asia. While environmental factors and genetic susceptibility play important roles in NPC pathogenesis, the Epstein–Barr virus in particular has been implicated in the molecular abnormalities leading to NPC. There is upregulation of cellular proliferation pathways such as the Akt pathway, mitogen‐activated protein kinases, and the Wnt pathway. Cell adhesion is compromised due to abnormal E‐cadherin and β‐catenin function. Aberrations in cell cycle are due to dysregulation of factors such as p16, cyclin D1, and cyclin E. Anti‐apoptotic mechanisms are also upregulated. There are multiple abnormalities unique to NPC that are potential targets for novel treatments. © 2008 Wiley Periodicals, Inc. Head Neck, 2008

[1]  F. He,et al.  Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma , 2007, Human mutation.

[2]  S. Tsao,et al.  Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases. , 2007, Cancer letters.

[3]  L. Chouchane,et al.  Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[4]  Rong Deng,et al.  Silencing of LMP1 Induces Cell Cycle Arrest and Enhances Chemosensitivity Through Inhibition of AKT Signaling Pathway in EBV-Positive Nasopharyngeal Carcinoma Cells , 2007, Cell cycle.

[5]  S. Tsao,et al.  Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells , 2007, Oncogene.

[6]  M. Kashani-Sabet,et al.  Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth. , 2007, Human gene therapy.

[7]  Su-ping Zhao,et al.  The Role of Enhanced Radiosensitivity and Tumor-specific Suicide Gene Vector in Genetherapy of Nasopharyngeal Carcinoma , 2007 .

[8]  Gui-yuan Li,et al.  BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating β-catenin and ERK pathways , 2007, Molecular and Cellular Biochemistry.

[9]  L. You,et al.  Wnt inhibitory factor inhibits lung cancer cell growth. , 2007, The Journal of thoracic and cardiovascular surgery.

[10]  Ying Liang,et al.  Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. , 2006, Cancer research.

[11]  M. Hirashima,et al.  Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9 , 2006, BMC Cancer.

[12]  B. O'Sullivan,et al.  Prognostic Significance of the Epstein-Barr Virus, p53, Bcl-2, and Survivin in Nasopharyngeal Cancer , 2006, Clinical Cancer Research.

[13]  A. Pinto,et al.  Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma , 2006, Cell Research.

[14]  P. Meltzer,et al.  Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase , 2006, International journal of cancer.

[15]  H. Dralle,et al.  CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma. , 2006, Thyroid : official journal of the American Thyroid Association.

[16]  E. Rosenthal,et al.  Matrix metalloproteases in head and neck cancer. , 2006, Head & neck.

[17]  N. Raab-Traub,et al.  LMP1 Strain Variants: Biological and Molecular Properties , 2006, Journal of Virology.

[18]  Z. Zeng,et al.  Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression , 2006, Journal of cellular biochemistry.

[19]  Xiaoling Li,et al.  Cloning and characterization of the BRD7 gene promoter. , 2006, DNA and cell biology.

[20]  W. Xiong,et al.  Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. , 2006, Human pathology.

[21]  Cheng-Ta Yang,et al.  Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines. , 2006, Biochemical and biophysical research communications.

[22]  Y. Lau,et al.  Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. , 2006, Neoplasia.

[23]  Xiaoqiu Chen,et al.  [The relationship between hypermethylation of the PTEN promoter and laryngeal squamous cell carcinoma]. , 2006, Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology.

[24]  Kim Js,et al.  The association between CD99 and LMP-1 expression in nasopharyngeal carcinoma. , 2006 .

[25]  K. Miyazaki,et al.  The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer , 2006, Journal of Gastroenterology.

[26]  H. Yao,et al.  Prognostic Value of Survivin and Livin in Nasopharyngeal Carcinoma , 2006, The Laryngoscope.

[27]  T. Golub,et al.  Epstein-Barr-Virus-Encoded LMP2A Induces Primary Epithelial Cell Migration and Invasion: Possible Role in Nasopharyngeal Carcinoma Metastasis , 2005, Journal of Virology.

[28]  Karin Milde-Langosch,et al.  The Fos family of transcription factors and their role in tumourigenesis. , 2005, European journal of cancer.

[29]  Y. Tao,et al.  Latent membrane protein 1 encoded by Epstein-Barr virus modulates directly and synchronously cyclin D1 and p16 by newly forming a c-Jun/Jun B heterodimer in nasopharyngeal carcinoma cell line. , 2005, Virus research.

[30]  N. Raab-Traub,et al.  Epstein–Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K , 2005, Oncogene.

[31]  Wei Shi,et al.  Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. , 2005, International journal of cancer.

[32]  Minrong Ai,et al.  Regulation of Survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines , 2005, Cell Research.

[33]  B. Ma,et al.  Celecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[34]  Y. Tao,et al.  Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells. , 2005, The international journal of biochemistry & cell biology.

[35]  Chih-Hung Hsu,et al.  Inhibitors of Epidermoid Growth Factor Receptor Suppress Cell Growth and Enhance Chemosensitivity of Nasopharyngeal Cancer Cells in vitro , 2005, Oncology.

[36]  H. Cheung,et al.  Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation , 2005, Molecular carcinogenesis.

[37]  M. Schell,et al.  Epstein‐Barr virus latent membrane protein 1 induces the matrix metalloproteinase‐1 promoter via an Ets binding site formed by a single nucleotide polymorphism: Enhanced susceptibility to nasopharyngeal carcinoma , 2005, International journal of cancer.

[38]  J. Sham,et al.  Nasopharyngeal carcinoma , 2005, The Lancet.

[39]  F. Tang,et al.  Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma. , 2005, Experimental oncology.

[40]  Biao He,et al.  Wnt signaling in lung cancer. , 2005, Cancer letters.

[41]  T. Putti,et al.  Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications , 2005, Journal of Clinical Pathology.

[42]  Amie Y Lee,et al.  Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations , 2005, Oncogene.

[43]  Y. Tao,et al.  [Cross-talk between c-Jun/Ets1 involved in EB virus-encoded latent membrane protein 1 regulates expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma]. , 2005, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[44]  Cristina M. Pinto,et al.  Retracted: Frequent genetic and biochemical alterations of the PI 3‐K/AKT/PTEN pathway in head and neck squamous cell carcinoma , 2005, International journal of cancer.

[45]  B. Steinberg,et al.  Phosphatidylinositol 3-kinase regulates early differentiation in human laryngeal keratinocytes , 2005, In Vitro Cellular & Developmental Biology - Animal.

[46]  N. Raab-Traub,et al.  Roles of the ITAM and PY Motifs of Epstein-Barr Virus Latent Membrane Protein 2A in the Inhibition of Epithelial Cell Differentiation and Activation of β-Catenin Signaling , 2005, Journal of Virology.

[47]  Y. Tao,et al.  Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1. , 2005, Experimental cell research.

[48]  Y. Kudo,et al.  Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma. , 2005, Oral oncology.

[49]  B. Goh,et al.  Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression. , 2005, Archives of otolaryngology--head & neck surgery.

[50]  I. Ernberg,et al.  Epstein‐Barr virus latent membrane 2A (LMP2A) down‐regulates telomerase reverse transcriptase (hTERT) in epithelial cell lines , 2005, International journal of cancer.

[51]  S. Bao,et al.  The activation of Akt/PKB signaling pathway and cell survival , 2005, Journal of cellular and molecular medicine.

[52]  Jen-Kuo Hwang,et al.  MDM2 expression in EBV-infected nasopharyngeal carcinoma cells , 2004, Laboratory Investigation.

[53]  J. Curnow,et al.  Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Hui-ying Yu,et al.  [Effects of basic fibroblast growth factor on protein kinase B activity and c-fos expression in CNE- I nasopharyngeal carcinoma cell line]. , 2004, Zhonghua er bi yan hou ke za zhi.

[55]  X. Huo,et al.  [Expression and significance of PTEN in nasopharyngeal carcinoma]. , 2004, Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology.

[56]  N. Raab-Traub,et al.  Accumulation of Cytoplasmic β-Catenin and Nuclear Glycogen Synthase Kinase 3β in Epstein-Barr Virus-Infected Cells , 2004, Journal of Virology.

[57]  Y. Tao,et al.  Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1. , 2004, Cellular signalling.

[58]  Mu-Kuan Chen,et al.  Expression of p53 protein and primary tumour volume in patients with nasopharyngeal carcinoma. , 2004, The Journal of otolaryngology.

[59]  X. Deng,et al.  Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells. , 2004, Journal of experimental & clinical cancer research : CR.

[60]  Yi Ren,et al.  Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. , 2004, Chinese medical journal.

[61]  M. Gulley,et al.  Differential Signaling Pathways Are Activated in the Epstein-Barr Virus-Associated Malignancies Nasopharyngeal Carcinoma and Hodgkin Lymphoma , 2004, Cancer Research.

[62]  J Silvio Gutkind,et al.  Global Gene Expression Profile of Nasopharyngeal Carcinoma by Laser Capture Microdissection and Complementary DNA Microarrays , 2004, Clinical Cancer Research.

[63]  H. Hsu,et al.  Cooperative interactions among p53, bcl‐2 and Epstein–Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells , 2004, Pathology international.

[64]  W. Xiong,et al.  BRD7, a novel bromodomain gene, inhibits G1–S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways , 2004, Journal of cellular physiology.

[65]  Y. Kwong,et al.  Clinicopathologic significance of plasma matrix metalloproteinase-2 and -9 levels in patients with undifferentiated nasopharyngeal carcinoma. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[66]  E. Ioachim,et al.  Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. , 2004, Journal of experimental & clinical cancer research : CR.

[67]  T. Yoshizaki,et al.  Epstein‐Barr Virus (EBV) Latent Membrane Protein 1 Induces Interleukin‐8 through the Nuclear Factor‐κB Signaling Pathway in EBV‐Infected Nasopharyngeal Carcinoma Cell Line , 2004, The Laryngoscope.

[68]  S. Akira,et al.  Elucidation of the c-Jun N-Terminal Kinase Pathway Mediated by Epstein-Barr Virus-Encoded Latent Membrane Protein 1 , 2004, Molecular and Cellular Biology.

[69]  M.D.,et al.  Prognostic Role of Ebstein-Barr Virus Latent Membrane Protein-1 and Interleukin-10 Expression in Patients with Nasopharyngeal Carcinoma , 2004 .

[70]  Pauline Chu,et al.  Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Mong-Hong Lee,et al.  Regulators of G1 cyclin–dependent kinases and cancers , 2003, Cancer and Metastasis Reviews.

[72]  W. Hung,et al.  RECK is a target of Epstein–Barr virus latent membrane protein 1 , 2003, Oncogene.

[73]  Jiang Li,et al.  Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer. , 2003, World journal of gastroenterology.

[74]  E. Hara,et al.  Epstein-Barr virus LMP1 blocks p16INK4a–RB pathway by promoting nuclear export of E2F4/5 , 2003, The Journal of cell biology.

[75]  J. Schouten,et al.  Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. , 2003, Archives of otolaryngology--head & neck surgery.

[76]  K. Schuebel,et al.  Epigenetic inactivation of CHFR in human tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[77]  R. Gilbert,et al.  Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[78]  Y. Wong,et al.  Alterations of Biologic Properties and Gene Expression in Nasopharyngeal Epithelial Cells by the Epstein-Barr Virus–Encoded Latent Membrane Protein 1 , 2003, Laboratory Investigation.

[79]  Tim Crook,et al.  The p53 network in head and neck cancer. , 2003, Oral oncology.

[80]  L. Hutt-Fletcher,et al.  A Positive Autoregulatory Loop of LMP1 Expression and STAT Activation in Epithelial Cells Latently Infected with Epstein-Barr Virus , 2003, Journal of Virology.

[81]  D. Crawford,et al.  Epstein-Barr virus-recent advances. , 2003, The Lancet. Infectious diseases.

[82]  F. Fang,et al.  Low expression levels of p27 correlate with loco-regional recurrence in nasopharyngeal carcinoma. , 2003, Cancer letters.

[83]  K. Lo,et al.  Genetic and epigenetic changes in nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.

[84]  A. Lin,et al.  The Absence of NF-κB-Mediated Inhibition of c-Jun N-Terminal Kinase Activation Contributes to Tumor Necrosis Factor Alpha-Induced Apoptosis , 2002, Molecular and Cellular Biology.

[85]  L. Matrisian,et al.  Matrix metalloproteinases in tumor-host cell communication. , 2002, Differentiation; research in biological diversity.

[86]  Stefania Staibano,et al.  Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[87]  C. Hwang,et al.  Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[88]  S. V. Anisimov,et al.  Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation revealed by serial analysis of gene expression. , 2002, Cancer research.

[89]  E. K. Parkinson,et al.  Telomerase inhibition and the future management of head-and-neck cancer. , 2002, The Lancet. Oncology.

[90]  Brian David Dynlacht,et al.  E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. , 2002, Genes & development.

[91]  D. Wong,et al.  Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. , 2002, Oral oncology.

[92]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[93]  M. Hurle,et al.  Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity. , 2002, Cancer research.

[94]  C. Dang,et al.  Translocations involving c-myc and c-myc function , 2001, Oncogene.

[95]  M. Chang,et al.  Association of p53 and BCL‐2 expression with Epstein‐Barr virus infection in the cancers of head and neck , 2001, Head & neck.

[96]  M. Sunagawa,et al.  Expression of p16, nm23‐H1, E‐cadherin, and CD44 Gene Products and Their Significance in Nasopharyngeal Carcinoma , 2001, The Laryngoscope.

[97]  H. Namba,et al.  Involvement of wild-type p53 in radiation-induced c-Jun N-terminal kinase activation in human thyroid cells. , 2001, Anticancer research.

[98]  H. Namba,et al.  Transient activation of c-Jun NH2-terminal kinase by growth factors influences survival but not apoptosis of human thyrocytes. , 2001, Thyroid : official journal of the American Thyroid Association.

[99]  G. Dong,et al.  IL (Interleukin)-1α Promotes Nuclear Factor-κB and AP-1-induced IL-8 Expression, Cell Survival, and Proliferation in Head and Neck Squamous Cell Carcinomas , 2001 .

[100]  T. Yoshizaki,et al.  Induction of cyclooxygenase-2 by Epstein–Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[101]  G. Wang,et al.  [Expression of telomerase subunits and its relationship with telomerase activity in nasopharyngeal carcinoma]. , 2001, Zhonghua yi xue za zhi.

[102]  C. Van Waes,et al.  Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[103]  Marc Schmidt,et al.  Ras-independent Activation of the Raf/MEK/ERK Pathway upon Calcium-induced Differentiation of Keratinocytes* , 2000, The Journal of Biological Chemistry.

[104]  S. H. Cheng,et al.  Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. , 2000, International journal of radiation oncology, biology, physics.

[105]  I. Stamenkovic Matrix metalloproteinases in tumor invasion and metastasis. , 2000, Seminars in cancer biology.

[106]  S. Maeda,et al.  Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma. , 2000, Cancer letters.

[107]  S. Elledge,et al.  The DNA damage response: putting checkpoints in perspective , 2000, Nature.

[108]  T. Halazonetis,et al.  Chfr defines a mitotic stress checkpoint that delays entry into metaphase , 2000, Nature.

[109]  T. Crook,et al.  High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? , 2000, Oncogene.

[110]  Liangguo Xu,et al.  Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array , 2000, Journal of Cancer Research and Clinical Oncology.

[111]  S. Dey,et al.  Host cyclooxygenase-2 modulates carcinoma growth. , 2000, The Journal of clinical investigation.

[112]  M. Gorospe,et al.  Inhibition of c-Jun N-Terminal Kinase 2 Expression Suppresses Growth and Induces Apoptosis of Human Tumor Cells in a p53-Dependent Manner , 2000, Molecular and Cellular Biology.

[113]  J F Barrett,et al.  Identification of CDK4 as a target of c-MYC. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[114]  W. Funkhouser,et al.  Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3 , 2000, Oncogene.

[115]  I. Koizuka,et al.  Absence of Nuclear p16 From Epstein‐Barr Virus‐Associated Undifferentiated Nasopharyngeal Carcinomas , 2000, The Laryngoscope.

[116]  N. Y. Chung,et al.  Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma , 1999, British Journal of Cancer.

[117]  J. Swantek,et al.  New insights into the control of MAP kinase pathways. , 1999, Experimental Cell Research.

[118]  K. Kawakami,et al.  A Selective Cyclooxygenase‐2 Inhibitor Suppresses Tumor Growth in Nude Mouse Xenografted with Human Head and Neck Squamous Carcinoma Cells , 1999, Japanese journal of cancer research : Gann.

[119]  S. Reed,et al.  Deregulated cyclin E induces chromosome instability , 1999, Nature.

[120]  W. Benedict,et al.  Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. , 1999, Human pathology.

[121]  A. Hui,et al.  Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation , 1999, International journal of cancer.

[122]  Hiroki Sato,et al.  Matrix Metalloproteinase 9 Expression Is Induced by Epstein-Barr Virus Latent Membrane Protein 1 C-Terminal Activation Regions 1 and 2 , 1999, Journal of Virology.

[123]  E. Prochownik,et al.  MYC oncogenes and human neoplastic disease , 1999, Oncogene.

[124]  C. Marshall,et al.  Activated MEK Stimulates Expression of AP-1 Components Independently of Phosphatidylinositol 3-Kinase (PI3-Kinase) but Requires a PI3-Kinase Signal To Stimulate DNA Synthesis , 1999, Molecular and Cellular Biology.

[125]  Fengzhi Li,et al.  Control of apoptosis and mitotic spindle checkpoint by survivin , 1998, Nature.

[126]  J C Reed,et al.  IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. , 1998, Cancer research.

[127]  E. Rosenthal,et al.  Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. , 1998, Cancer research.

[128]  U. Rapp,et al.  Cell cycle targets of Ras/Raf signalling , 1998, Oncogene.

[129]  Y. Bang,et al.  Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. , 1998, Biochemical and biophysical research communications.

[130]  A. Yang,et al.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.

[131]  J. Marks,et al.  The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma , 1998, Cancer.

[132]  R. DuBois,et al.  Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.

[133]  M. Spitz,et al.  Alterations of p53, cyclin D1, rb, and H‐ras in human oral carcinomas related to tobacco use , 1998, Cancer.

[134]  Tomohiko Maehama,et al.  The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[135]  L. Young,et al.  Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) , 1998, Oncogene.

[136]  M. Gulley,et al.  Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product. , 1998, The American journal of pathology.

[137]  J. Cooper,et al.  Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[138]  Yue Xiong,et al.  ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways , 1998, Cell.

[139]  A. E. Rogers,et al.  Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.

[140]  B. Dörken,et al.  Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. , 1997, The Journal of clinical investigation.

[141]  Y. F. Poon,et al.  Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. , 1997, Hong Kong medical journal = Xianggang yi xue za zhi.

[142]  W. Ansorge,et al.  Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes , 1997, Oncogene.

[143]  L. Matrisian,et al.  Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.

[144]  T. Panzarella,et al.  Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas. , 1997, International journal of radiation oncology, biology, physics.

[145]  D. Altieri,et al.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.

[146]  I. McKillop,et al.  Increased MAPK expression and activity in primary human hepatocellular carcinoma. , 1997, Biochemical and biophysical research communications.

[147]  M. Vasef,et al.  Nasopharyngeal Carcinoma, with Emphasis on its Relationship to Epstein-Barr Virus , 1997, The Annals of otology, rhinology, and laryngology.

[148]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[149]  R. Davis,et al.  The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. , 1996, The Journal of biological chemistry.

[150]  R. Kerbel,et al.  Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents , 1996, Nature Medicine.

[151]  A. Franchi,et al.  Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[152]  J. Bartek,et al.  High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. , 1996, Cancer research.

[153]  F. Larcher,et al.  Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[154]  W. Lee,et al.  Down regulation of bcl‐2 by p53 in nasopharyngeal carcinoma and lack of detection of its specific t(14;18) chromosomal translocation in fixed tissues , 1996, Histopathology.

[155]  R. Treisman,et al.  Regulation of transcription by MAP kinase cascades. , 1996, Current opinion in cell biology.

[156]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[157]  J. Sham,et al.  ras mutations are uncommon in nasopharyngeal carcinoma. , 1995, European journal of cancer. Part B, Oral oncology.

[158]  O Yoshida,et al.  Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. , 1995, Cancer research.

[159]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[160]  F. Eschwège,et al.  Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. , 1995, International journal of radiation oncology, biology, physics.

[161]  W. Nelson,et al.  Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[162]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[163]  A. Hart,et al.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. , 1995, Cancer research.

[164]  J. O'Connell,et al.  Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A. , 1994, Biochemistry.

[165]  E. Kieff,et al.  An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[166]  B. Gallie,et al.  The retinoblastoma protein and the cell cycle. , 1992, Seminars in cancer biology.

[167]  Q Y Yao,et al.  Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts , 1992, Journal of virology.

[168]  A. Seymour Histological Typing of Tumours of the Upper Respiratory Tract and Ear , 1991 .

[169]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[170]  D. Kondziolka,et al.  Stereotactic radiosurgery for squamous cell carcinoma of the nasopharynx , 1991, The Laryngoscope.

[171]  R. Schreiber,et al.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.

[172]  E. Kieff,et al.  Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1 , 1990, Journal of virology.

[173]  J. Sham,et al.  Detection of subclinical riasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy , 1990, The Lancet.

[174]  G. Bepler,et al.  Epidermal growth factor receptor expression in human lung cancer cell lines. , 1988, Cancer research.

[175]  H. Moses,et al.  Growth factors and cancer. , 1986, Cancer research.

[176]  E. Kieff,et al.  An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells , 1985, Cell.

[177]  M. Kondo,et al.  Squamous cell carcinoma of the nasopharynx. An analysis of failure patterns after radiation therapy. , 1985, Acta radiologica. Oncology.

[178]  G. Shklar,et al.  Oral mucosal tumor inhibition by ibuprofen. , 1983, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[179]  R. R. Howe,et al.  Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. , 1982, The New England journal of medicine.

[180]  J. P. Hansen,et al.  Nasopharyngeal cancer in Greenland. The incidence in an Arctic Eskimo population. , 1977, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[181]  P. Buell The effect of migration on the risk of nasopharyngeal cancer among Chinese. , 1974, Cancer research.

[182]  V. Diehl,et al.  Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. , 1969, Journal of the National Cancer Institute.

[183]  Zhe Zhang,et al.  Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma , 2007, International journal of cancer.

[184]  Z. Zeng,et al.  Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. , 2007, Human pathology.

[185]  Yuxiang He,et al.  Role of enhanced radiosensitivity and the tumor-specific suicide gene vector in gene therapy of nasopharyngeal carcinoma. , 2007, Journal of radiation research.

[186]  Wen-Qi Jiang,et al.  [Significance of EGFR and p-ERK expression in nasopharyngeal carcinoma]. , 2006, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[187]  M. C. Lee,et al.  The association between CD99 and LMP-1 expression in nasopharyngeal carcinoma. , 2006, Experimental oncology.

[188]  J. Burgos Involvement of the epstein-barr virus in the nasopharyngeal carcinoma pathogenesis , 2005, Medical oncology.

[189]  K. Marumo,et al.  Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN‐mutated prostate cancer cells , 2005, The Prostate.

[190]  Massimo Loda,et al.  Role of p27 in Prostate Carcinogenesis , 2004, Cancer and Metastasis Reviews.

[191]  Ching‐Hwa Tsai,et al.  Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins. , 2003, Cancer research.

[192]  Ya Cao,et al.  Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-κB and AP-1 , 2003, Cell Research.

[193]  C. Harris,et al.  Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. , 2003, The Journal of clinical investigation.

[194]  T. West,et al.  HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis. , 2002, Clinical otolaryngology and allied sciences.

[195]  J. Rubin,et al.  Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas , 2002, Oncogene.

[196]  P. Johnson,et al.  Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[197]  B. Fingleton,et al.  Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. , 2001, Neoplasia.

[198]  Y. Nagashima,et al.  Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma. , 2001, Cancer detection and prevention.

[199]  Q. Chen,et al.  Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. , 2000, Oral oncology.

[200]  C. Sherr Cell cycle control and cancer. , 2000, Harvey lectures.

[201]  堀川 利之 Association of Latent Membrane Protein 1 and Matrix Metalloproteinase 9 with Metastasis in Nasopharyngeal Carcinoma , 2000 .

[202]  J. Abbruzzese,et al.  The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[203]  A. Hill,et al.  Lack of correlation between G1 arrest and radiation age-response in three synchronized human tumour cell lines. , 1999, International journal of radiation biology.

[204]  Douglas B. Evans,et al.  The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells , 1999 .

[205]  李晓燕,et al.  Detection of c-myc gene expression in nasopharyngeal carcinoma by nonradioactive in situ hybridization and immunohistochemistry , 1997 .

[206]  G. Cooper The Cell: A Molecular Approach , 1996 .

[207]  D. Spandidos,et al.  The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. , 1994, Acta oto-laryngologica.

[208]  D M Parkin,et al.  Cancer Incidence in Five Continents. Comparability and quality of data. , 1992, IARC scientific publications.

[209]  Parkin Dm,et al.  Cancer Incidence in Five Continents. Comparability and quality of data. , 1992 .

[210]  D. Choy,et al.  Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. , 1990, The British journal of radiology.

[211]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[212]  J. Yates,et al.  Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells , 1985, Nature.

[213]  B. Henderson,et al.  Nasopharyngeal carcinoma in Chinese---salted fish or inhaled smoke? , 1981, Preventive medicine.